Estrogen receptors in hip joint capsule and ligamentum capitis femoris of babies with

Amaç: Çalışmamızın amacı insan kalça eklem kapsülü ve ligamentum capitis femorislerindeki östrojen reseptörü varlığını saptamaktı. Çalışma planı: Gelişimsel kalça displazisi (GKD) nedeniyle ameliyat edilen 15 hastanın ve kontrol grubu olarak da 15 intrauterin ölü fetüsün toplam 30 kalçasından ligamentum capitis femoris (LCF) ve kalça eklem kapsülü biyopsileri alındı. Olguların cerrahi sırasında ortalama yaşı 10.3 (dağılım: 6-18) ay idi. Tam kat 1x1 cm anterior kapsül ve LCF örnekleri biyopsi olarak alındı. Kalça eklem kapsülü ve LCF’de bulunan hedef östrojen hücrelerinin oranını saptamak için monoklonal östrojen reseptör antikorları kullanılarak immünohistokimyasal bir çalışma yapıldı. Bulgular: Kontrol grubundaki LCF örneklerinde saptanan östrojen reseptörü (ÖR) boyanma oranı 1.6±0.2%, kalça eklem kapsülünde ise 1.3±0.2% idi. GKD bulunan grupta ise LCF örneklerinde saptanan ÖR boyanma oranı 2.5±0.3% , kalça eklem kapsülünde ise 2.0±0.3% idi. LCF ve kalça eklem kapsülünde ÖR boyanma oranının kontrol grubunda GKD bulunan gruba göre istatistiksel olarak anlamlı şekilde az olduğu gözlendi (p

Gelişimsel kalça displazili bebeklerde kalça eklem kapsülü ve ligamentum kapitis femoriste östrojen reseptörlerinin saptanması

Objective: The aim of this study was to detect the incidence of estrogen receptors in human hip joint capsule and ligamentum teres. Methods: The study included biopsies of the ligamentum capitis femoris (LCF) and hip joint capsule from 15 patients undergoing hip surgery for developmental dysplasia of the hip (DDH) and from the control hips of 15 cases of intrauterine fetal death. Mean age was 10.3 (range: 6 to 18) months at the time of surgery. Full-thickness 1x1 cm anterior capsule and LCF portions were taken as biopsy specimens. An immunohistochemical study using monoclonal antibody against estrogen receptors was performed to identify the rate of target estrogen cells in the hip joint capsule and LCF. Results: Estrogen receptor (ER) staining rates were 1.6±0.2% for the LCF and 1.3±0.2% for the hip joint capsule in the control groups, and 2.5±0.3% for the LCF and 2.0±0.3% for the hip joint capsule in the DDH groups. Estrogen receptor staining rates in the LCF and hip joint capsule control groups were significantly lower than that in the DDH groups (p<0.001). In both groups, ER rates were significantly lower in the hip joint capsule than in the LCF (p<0.01). Conclusion: The high rate of ERs in the LCF and hip joint capsule appears to support the effect of estrogen in the etiology of the DDH.

___

1. Carter CO, Wilkinson JA. Genetic and environmental fac- tors in the etiology of congenital dislocation of the hip. Clin Orthop Relat Res 1964;(33):119-28.
2. Dunn PM. Prenatal observation on the etiology of congeni- tal dislocation of the hip. Clin Orthop Relat Res 1976;(119):11-22.
3. Wilkinson JA. Prime factors in the etiology of congenital dislocation of the hip. J Bone Joint Surg Br 1963;45:268-83.
4. Wynne-Davies R. Acetabular dysplasia and familial joint lax- ity: two etiological factors in congenital dislocation of the hip. A review of 589 patients and their families. J Bone Joint Surg Br 1970;52:704-16.
5. Suzuki S, Yamamuro T. Correlation of fetal posture and congenital dislocation of the hip. Acta Orthop Scand 1986;57:81-4.
6. Akeson WH, Woo SL, Amiel D, Doty DH, Rutherford L. Value of 17beta-oestradiol in prevention of contracture for- mation. Ann Rheum Dis 1975;35:429-36.
7. Liu SH, Al-Shaikh RA, Panossian V, Finerman GA, Lane JM. Estrogen affects the cellular metabolism of the anterior cruciate ligament. A potential explanation for female athlet- ic injury. Am J Sports Med 1997;25:704-9.
8. Brenner RM, West NB, McClellan MC. Estrogen and prog- estin receptors in the reproductive tract of male and female primates. Biol Reprod 1990;42:11-9.
9. Aarskog D, Stoa KF, Thorsen T. Urinary oestrogen excre- tion in newborn infants with congenital dislocation of the hip joint. Acta Paediatr Scand 1966;55:394-7.
10. Andren L, Borglin NE. Disturbed urinary excretion pattern of oestrogens in newborns with congenital dislocation of the hip. 1. The excretion of oestrogen during the first few days of life. Acta Endocrinol (Copenh) 1961;37:423-6.
11. Andersson JE, Vogel I, Uldbjerg N. Serum 17 beta-estradi- ol in newborn and neonatal hip instability. J Pediatr Orthop 2002;22:88-91.
12. Nakamura Y, Hirano S, Suzuki K, Seki K, Sagara T, Nishida T. Signaling mechanism of TGF-β1-induced collagen con- traction mediated by bovine trabecular meshwork cells. Invest Ophthalmol Vis Sci 2003;44:4331-6.
13. Diaz-Chavez J, Hernandez-Pando R, Lambert FP, Gariglio P. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer. Mol Cancer 2008;7:3.
14. Shynlova O, Mitchell JA, Tsampalieros A, Langille BL, Lye SJ. Progesterone and gravidity differentially regulate expres- sion of extracellular matrix components in the pregnant rat myometrium. Biol Reprod 2004;70:986-92.
15. Fischer GM, Swain ML. Effect of sex hormones on blood pressure and vascular connective tissue in castrated and non- castrated male rats. Am J Physiol 1977;232:617-21.
16. Hama H, Yamamuro T, Takeda T. Experimental studies on connective tissue of the capsular ligament. Influences of aging and sex hormones. Acta Orthop Scand 1976;47:473-9.
17. Shikata J, Sanada H, Tamamuro T, Takeda T. Experimental studies of the elastic fiber of the capsular ligament: influence of aging and sex hormones on the hip joint capsule of rats. Connect Tissue Res 1979;7:21-7.
18. Yamamuro T, Hama H, Takeda T, Shikata J, Sanada H. Biomechanical and hormonal factors in the etiology of con- genital dislocation of the hip joint. Int Orthop 1977;1:231-6.